News and Announcements
Universal Biosensors Q3 2015 Results, Investor Presentation and CEO Audio Interview
- Published October 30, 2015 12:16PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th October 2015, ASX Announcement
- Total revenue up 187% on pcp to $6.0m
- Quarterly Service Fees up 113% on pcp to $3.4m
- Coagulation strip manufacturing revenue up 303% on pcp to $553k
- Net R&D costs (including accrued R&D tax rebate) of $2.6m
- Net loss of 163k (down from $1.9m on pcp)
- Cash balance as at 30 September 2015 of $17.4m
To read the full announcement, please click here.
To view the Investor Presentation, please click here.
To listen to the CEO Interview, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
